Evaluation of a Gatekeeper Training for Pharmacists
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05991635 |
Recruitment Status :
Completed
First Posted : August 14, 2023
Last Update Posted : February 6, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Suicide | Behavioral: Gatekeeper training (e-learning) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 201 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Evaluation of a Gatekeeper Training for Pharmacists |
Actual Study Start Date : | April 12, 2023 |
Actual Primary Completion Date : | January 11, 2024 |
Actual Study Completion Date : | January 11, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention group
Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online gatekeeper training (e-learning) during three days, after which they were asked to complete another questionnaire. After three months, a third questionnaire is sent.
|
Behavioral: Gatekeeper training (e-learning)
The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are:
|
- Changes in attitudes: Attitudes Towards Suicide Scale (ATTS) [ Time Frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning) ]The ATTS is a 37-item to be scored on a 5-point Likert scale (1= disagree completely to 5 = agree completely) to measure participants' attitudes towards suicide.
- Changes in self-efficacy: Measurement of Perceived Self-efficacy [ Time Frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning) ]The Measurement of Perceived Self-efficacy is a 10-item self-report questionnaire to be scored on a 4-point Likert scale (1= Completely false to 4 = completely true)
- Changes in perceptions/myths [ Time Frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning) ]Self-developped questionnaire: 4 statements to be rated as true or false; 2 question about how participant would feel if a patient said they have suicidal thouhgts
- Gatekeeper training evaluation [ Time Frame: Post-test (after a week of access to e-learning) ]
8 evaluative statements about the e-learning to be rated on a 5-point Likert scale (Totally disagree, disagree, neutral, agree, totally disagree).
Question to rate the e-learning on a scale of 1 (not good at all) to 10 (excellent) Additionally three open questions where participants can give feedback about what they liked/did not like/ general comments.
- Socio-demographic characteristics [ Time Frame: Baseline ]Age, Gender, Years of work experience
- Previous experience with suicide (prevention) [ Time Frame: Baseline and post-test (after a week of access to e-learning) ]At baseline: motivation to participate (9 options), previous trainings (yes/no, specify if yes) At baseline and post-test: experience with suicidal patients (contact and confidence; 5 point Likert scale), knowing what to do or who to refer to (5-point Likert scale), knowing where to find information (5-point Likert scale), which actions previously taken in case of suicidal patient (list of 12), to who do you refer (5 options)
- Follow-up [ Time Frame: Follow-up (three months after baseline) ]Questions concerning: application of acquired skills and knowledge; actions undertaken in context of suicide prevention (12 options); experienced barriers to application of acquired skills and knowledge; need of extra support
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- ≥ 18 years old
- Have access to internet
- Speak Dutch
- Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
Exclusion Criteria:
- Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05991635
Belgium | |
Flemish Centre of Expertise in Suicide Prevention, Ghent University | |
Ghent, Belgium, 9000 |
Principal Investigator: | Gwendolyn Portzky, Phd | University Ghent |
Responsible Party: | University Ghent |
ClinicalTrials.gov Identifier: | NCT05991635 |
Other Study ID Numbers: |
ONZ-2022-0598 |
First Posted: | August 14, 2023 Key Record Dates |
Last Update Posted: | February 6, 2024 |
Last Verified: | February 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Suicide Self-Injurious Behavior Behavioral Symptoms |